Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionThe dynamics of human cytomegalovirus replication in vivoAltered antibody profiles against common infectious agents in chronic diseaseCytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South AfricaA prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantationCMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study.Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central ChinaGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerCytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDSQuantitative molecular analysis of virus expression and replication.Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patientsValue of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.Evaluation of the ReSSQ assay in relation to the COBAS AMPLICOR CMV MONITOR test and an in-house nested PCR method for detection of cytomegalovirus DNA.Diagnostic virology.CMV retinitis in China and SE Asia: the way forward.Is cytomegalovirus viraemia a useful tool in managing CMV disease?Investigation of CMV disease in immunocompromised patientsDetection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.Changing therapeutic paradigms in CMV retinitis in AIDS.Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theDiagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation.Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesisThe use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.Management of CMV disease in HIV infection.Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era.Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group.Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent miceCytomegalovirus viral load kinetics in patients with HIV/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapyHigh seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, NigeriaAssociations between virologic and immunologic dynamics in blood and in the male genital tract.A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection.Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infantsManagement of patients with HIV in the intensive care unitVertical Cytomegalovirus Transmission From HIV-Infected Women Randomized to Formula-Feed or Breastfeed Their InfantsThe detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants.CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infectionLow rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.
P2860
Q24550678-EBE221ED-509A-4B9A-A159-28809671F58DQ28141142-23EA6EE2-941F-42B5-80F9-316C477216FFQ28661374-1D631006-4726-4E0A-B778-681F1750852EQ28743974-475BB807-4A73-413C-AC37-0272BA3C70CCQ33264234-9FE82348-4CD1-4915-BC6A-298C031F18D2Q33305154-9EB1E998-5D9D-4AC4-9098-63ECB7567A6BQ33528999-A679CA24-3180-4BD2-93B4-4B5367A46531Q33629698-FBB77553-893D-4683-9597-D2DA32C5B467Q33650105-FD547E0F-8384-4E92-9B60-49E0546B890DQ33818170-B62ED01E-2DE8-4C80-B275-E74042998940Q33931554-0A43D04F-F37C-41F8-8F42-26B101DDB46EQ33962859-5EB954B5-5552-4978-B99A-435827B8EA89Q33965303-31536366-66CF-46E2-B301-B79945A60EC1Q34041788-7AE3F928-E737-4EC7-AF76-BCD2FF818B34Q34052588-5FA2FB3B-1D15-4E6C-BA10-E979237F21D2Q34083147-149C4D2B-31DB-4844-8C88-2424304F87D5Q34120674-2002DB75-49E9-4D48-9EB3-8FDD0C4324D3Q34160042-E2F4B1AD-D4E3-4BEA-866A-980678724BE2Q34174051-DC17B788-AB5F-4301-9120-9FC44986ED9AQ34181810-876AF6DE-D57A-4B66-8D91-788725C0A389Q34191791-0F518463-0AD1-436B-832D-815B34A716D2Q34212799-0BB2BD57-AF43-45E6-92F2-69E60C24A7FDQ34294843-3080ECC4-5618-4769-B449-8EF66357CE88Q34343874-48BB35B0-D84C-4568-B2E5-7AAAD1D61058Q34652175-08E08F62-F814-4F0E-9D28-41BA4E5B5AACQ34660073-C4CF1CAF-70B1-4126-99E9-0CBBF03B716DQ34750093-26B830B0-C9BA-47AE-856B-F091C0768AF0Q34792820-EEA98A05-8BCE-4A69-90DA-0C73E771E8A9Q35024244-2B0F2337-7A0A-4FA8-8E92-651C46A2221EQ35139226-19EE397F-005C-4C9D-9A79-B406EC3A4FBBQ35207396-B8BE0DA7-6AE3-489A-BDFD-6326A1CC85CEQ35689689-570BB948-BE9F-4798-A1B7-45B4E73EB0E8Q35855436-0293B717-A214-433B-9AC7-BF45DC3D24A4Q36276152-33B99EC8-F8CD-4949-8BE3-1DC4A6C27F77Q36403151-661FBAE5-5435-4107-BBDA-6AF422D3BCD4Q36597761-B228A207-3F1C-47B1-9D6D-569A60CF6239Q37336986-F104A2D9-5614-4C13-BF60-804342DDBFF4Q37341040-55F4788C-51C8-40E7-8515-66461038CB31Q37368001-B05F7161-9765-4DAA-87D4-E142FC86A0D5Q39445849-B08E8476-835A-4D82-B462-E4462AD6309C
P2860
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
@en
Plasma cytomegalovirus
@nl
type
label
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
@en
Plasma cytomegalovirus
@nl
prefLabel
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
@en
Plasma cytomegalovirus
@nl
P2093
P2860
P356
P1476
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
@en
P2093
P2860
P304
P356
10.1172/JCI1101
P407
P577
1998-01-01T00:00:00Z